Davis Jason

Davis Jason is listed in filings as Chief Financial Officer at FibroBiologics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 4, 2026, including purchase activity. Recent filings connect the profile to FibroBiologics, Inc. Common Stock (FBLG). The current snapshot covers public activity from Jun 10, 2025 to May 4, 2026. Reported amounts are shown as $85.0K to $425.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.